Cottrell, E., Maharaj, A., Williams, J., Chatterjee, S., Cirillo, G., Miraglia del Giudice, E., … Storr, H. L. (2022). Growth Hormone Receptor (GHR) 6Ω Pseudoexon Activation: A Novel Cause of Severe Growth Hormone Insensitivity. The Journal of Clinical Endocrinology & Metabolism, 107(1), e401–e416. https://doi.org/10.1210/clinem/dgab550

Cottrell, Emily, Avinaash Maharaj, Jack Williams, Sumana Chatterjee, Grazia Cirillo, Emanuele Miraglia del Giudice, Adalgisa Festa, et al. “Growth Hormone Receptor (GHR) 6Ω Pseudoexon Activation: A Novel Cause of Severe Growth Hormone Insensitivity.” The Journal of Clinical Endocrinology & Metabolism 107, no. 1 (January 1, 2022): e401–16. https://doi.org/10.1210/clinem/dgab550.

Cottrell E, Maharaj A, Williams J, Chatterjee S, Cirillo G, Miraglia del Giudice E, et al. Growth Hormone Receptor (GHR) 6Ω Pseudoexon Activation: A Novel Cause of Severe Growth Hormone Insensitivity. The Journal of Clinical Endocrinology & Metabolism. 2022 Jan 1;107(1):e401–16.

Cottrell, Emily, et al. “Growth Hormone Receptor (GHR) 6Ω Pseudoexon Activation: A Novel Cause of Severe Growth Hormone Insensitivity.” The Journal of Clinical Endocrinology & Metabolism, vol. 107, no. 1, The Endocrine Society, Jan. 2022, pp. e401–16. Crossref, doi:10.1210/clinem/dgab550.

Cottrell E, Maharaj A, Williams J, Chatterjee S, Cirillo G, Miraglia del Giudice E, Festa A, Palumbo S, Capalbo D, Salerno M, Pignata C, Savage MO, Schilbach K, Bidlingmaier M, Hwa V, Metherell LA, Grandone A, Storr HL. Growth Hormone Receptor (GHR) 6Ω Pseudoexon Activation: A Novel Cause of Severe Growth Hormone Insensitivity. The Journal of Clinical Endocrinology & Metabolism. The Endocrine Society; 2022 Jan 1;107(1):e401–e416.